Run-level NGS QC starts with four essential metrics: alignment rate, duplication rate, transition/transversion (Ti/Tv) ratio, and heterozygous/homozygous (Het/Hom) ratio. Laboratories must monitor these during clinical validation to detect contamination, over-amplification, or artifactual variant calls. Outliers are evaluated contextually—a single out-of-range value doesn’t automatically fail a run, but multiple concurrent flags trigger technical investigation to preserve diagnostic accuracy.
The true power of NGS run metrics lies not in rigid cutoff rules, but in distinguishing technical noise from biological signal. A single outlier can reflect a true patient mosaic, while a pattern of out‑of‑bounds ratios almost always points to a systematic lab issue. The goal is to build a trend‑aware QC framework that protects patient results while avoiding unnecessary re‑sequencing.
The Four Pillars of Run-Level NGS Quality Control
Each metric offers a specific window into the integrity of the sequencing process. Monitored together, they provide a holistic view of run health long before variant interpretation begins.
% Aligned – Detecting Contamination and Sample Degradation
The percentage of reads that align to the reference genome is a first-line indicator of sample purity. Low alignment rates often signal microbial DNA contamination or severe sample degradation. For diagnostic labs, a drop below an established threshold usually triggers re‑extraction or library re‑preparation, because misaligned reads can easily mask true pathogenic variants.
% Duplicate – Unmasking Amplification Bottlenecks
Duplicate reads—fragments with identical start and end points—primarily arise during PCR over‑amplification or flow‑cell clustering issues. Elevated duplication reduces the effective unique coverage, weakening the ability to call low‑frequency variants. When duplicate rates spike, the root cause is almost always technical, demanding adjustment of library amplification cycles or template concentration.
Ti/Tv Ratio – Guarding Against Artifactual Variant Calls
The transition‑to‑transversion ratio reflects the underlying chemistry of mutation. In healthy human exomes, a Ti/Tv ratio around 2.8–3.0 is typical. Deviations, especially in GC‑rich regions, expose sequencing‑artifact peaks that can masquerade as true variants. An abnormal ratio forces a careful review of called variants to ensure no false positives slip into a clinical report.
Het/Hom Ratio – Revealing Sample Mixtures and Ploidy Anomalies
The heterozygous‑to‑homozygous variant ratio is a sensitive probe for sample purity and contamination. An out‑of‑range Het/Hom ratio may indicate two individuals in one sample, mosaicism, or chimerism. In a run validation context, it is one of the most reliable red flags that a sample does not represent the intended patient alone.
Evaluating Metric Outliers: From Single Flags to Run Decisions
Not every alert means the run is invalid. Clinical laboratories need a decision framework that balances sensitivity with practical throughput.
The Single-Outlier Exception
A single metric moving slightly outside its acceptance range can stem from biological individuality, not technical failure. A patient with clonal haematopoiesis, for example, may naturally skew mutation ratios. For this reason, individual outliers are noted and trended but rarely trigger immediate run rejection on their own.
The Multiple-Outlier Rule
When two or more metrics deviate simultaneously, the probability of a systematic technical error spikes dramatically. This pattern—low alignment, high duplication, and altered Ti/Tv all at once—demands an immediate root‑cause investigation. Lab teams typically examine reagent lots, instrument performance, and sample handling processes to identify the common denominator.
Setting Actionable Thresholds
Baseline acceptance criteria cannot be copied from another lab; they must be derived from in‑house validation data using stable reference samples. Monthly and annual trend‑monitoring controls then refine these thresholds, catching slow drift before it compromises a diagnostic run. The best QC programs treat thresholds as living numbers, not static cutoffs.
Understanding the Trade-offs and Common Pitfalls
Tight QC metrics catch problems early, but over‑rigid rules can cause as much harm as they prevent.
False alarms waste resources. If thresholds are too narrow, benign sample variations will repeatedly force unnecessary re‑sequencing, delaying patient results and inflating costs. The diagnostic community learns to distinguish between a statistical fluctuation and a true quality breach by coupling metric monitoring with orthogonal checks like visual inspection of variant calls.
Biological outliers are not errors. A genuine somatic mosaicism can push the Het/Hom ratio outside normal bounds, yet the result is clinically vital. Treating every outlier as a technical fault risks erasing the precise signals that NGS is meant to uncover. The art of QC is asking, "Does this deviation make biological sense for this patient?"
Single metrics are blinkered. Relying on only one or two indicators creates blind spots. A run can maintain excellent alignment and duplication rates while generating artifact‑rich variant calls that the Ti/Tv ratio would immediately flag. A balanced panel of metrics—run‑level, alignment‑level, and variant‑level—is the only way to gain true confidence in a diagnostic result.
Making the Right Choice for Your Validation Framework
The specific metrics you prioritize and how you respond to outliers should map directly to your lab’s clinical mission.
- If your primary focus is minimizing false‑negative results: Emphasize recovery of low‑allele‑fraction variants by tolerating slightly higher duplication and deeply investigating any drop in alignment rate that could obscure a real call.
- If your primary focus is avoiding false‑positive calls that lead to harmful interventions: Set stricter Ti/Tv and Het/Hom thresholds, and automatically review any sample that pushes these boundaries before signing out a report.
- If your primary focus is run‑level throughput and cost efficiency: Use the multiple‑outlier rule as your main go/no‑go gate, and invest in trend‑monitoring controls that catch reagent‑lot drift early, preventing batch failures.
- If your primary focus is building a brand‑new validation from scratch: Start with a small set of well‑characterized control samples to define your lab‑specific baseline, then expand metric monitoring as you accumulate longitudinal data.
Trustworthy clinical NGS does not come from a magic number—it comes from a disciplined system that listens to what a handful of key metrics are saying about each run, each sample, and each patient.
Summary Table:
| QC Metric | Primary Diagnostic Indicator | Target Baseline Insight | Cause & Action for Metric Outliers |
|---|---|---|---|
| % Aligned | Sample Purity & Degradation | High alignment to reference genome | Low rates indicate microbial contamination or degraded DNA; requires re-extraction. |
| % Duplicate | Amplification Bottlenecks | Low duplication percentage | High rates stem from PCR over-amplification; adjust cycle count or template concentration. |
| Ti/Tv Ratio | Sequencing Chemistry Integrity | ~2.8–3.0 for human exomes | Deviations flag artifactual variant calls; perform detailed variant review before reporting. |
| Het/Hom Ratio | Sample Purity & Contamination | Expected heterozygous/homozygous balance | Outliers indicate sample mixtures, chimerism, or mosaicism; evaluate biological vs. technical cause. |
Optimize Your Diagnostic Assay Validation with CamelBio
Building robust NGS quality control frameworks and developing clinical diagnostic assays requires uncompromised material quality and rigorous technical validation. CamelBio provides diagnostic manufacturers, clinical laboratories, and research institutes with high-performance IVD raw materials, specialized technical services, and end-to-end consulting—supporting every stage of your assay workflow from concept to clinic.
Whether you are establishing validation baselines, resolving technical sequencing artifacts, or scaling IVD production, our technical experts are ready to empower your lab's performance.
Contact CamelBio Today to Accelerate Your Clinical Diagnostic Success